Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | APAF1 | O14727 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL14739087 | 0.93 | FDPS (0.37) | FDPSSMN1; SMN2LMNAMEN1APAF1 | |
| Propionic Acid SCHEMBL28053580 | 0.90 | FDPS (0.39) | FDPSSMN1; SMN2LMNAMEN1APAF1 | |
| Glycine SCHEMBL31241250 | 0.89 | FDPS (0.38) | FDPSSMN1; SMN2LMNAMEN1APAF1 | |
| SCHEMBL205339 | 0.88 | — | — | |
| Urea SCHEMBL29001562 | 0.87 | SMN1; SMN2 (0.39) | FDPSSMN1; SMN2LMNAMEN1APAF1 | |
| Butyric Acid SCHEMBL28053654 | 0.86 | FFAR3 (0.40) | FDPSSMN1; SMN2LMNAMEN1APAF1 | |
| Formic Acid SCHEMBL17076871 | 0.86 | FDPS (0.40) | FDPSSMN1; SMN2LMNAMEN1APAF1 | |
| Iodide SCHEMBL898865 | 0.86 | MEN1 (0.43) | FDPSSMN1; SMN2LMNAMEN1APAF1 | |
| Fluoride Ion SCHEMBL4200937 | 0.86 | SMN1; SMN2 (0.43) | FDPSSMN1; SMN2LMNAMEN1APAF1 | |
| Bromide SCHEMBL21777067 | 0.86 | SMN1; SMN2 (0.43) | FDPSSMN1; SMN2LMNAMEN1APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119777031-A | Polysaccharide-based thermoplastic composite fiber and preparation method thereof | 中国科学院化学研究所 | 2025-04-08 | — | — | CN | claimed |
| CN-115260839-B | Use of ionic polysaccharide derivatives as antifog coating materials | 中国科学院化学研究所 | 2023-04-14 | — | — | CN | claimed |
| CN-115634315-A | Regenerated cellulose-based blood vessel or blood vessel patch and preparation method thereof | 华南理工大学 | 2023-01-24 | — | — | CN | claimed |
| CN-115215943-A | Organic room temperature phosphorescent polymer material and preparation method and application thereof | 中国科学院化学研究所 | 2022-10-21 | — | — | CN | claimed |
| CN-111621648-B | Silver solution and preparation method thereof | 中国科学院化学研究所 | 2021-08-31 | — | — | CN | claimed |
| CN-109111516-B | Method for extracting wool keratin | 浙江理工大学 | 2021-08-27 | — | — | CN | claimed |
| CN-112816530-A | Preparation method of photoelectrochemical immunosensor for detecting keratin | 浙江理工大学 | 2021-05-18 | — | — | CN | claimed |
| CN-110130094-B | Activated plant fiber, preparation method thereof and application thereof in polylactic acid composite material | 东华大学 | 2020-12-22 | — | — | CN | claimed |
| CN-112064392-A | Biomass pretreatment composition and biomass pretreatment method | 中国科学院化学研究所 | 2020-12-11 | — | — | CN | claimed |
| CN-111840569-A | PH-responsive drug-loaded nanoparticle | 嘉兴市轩禾园艺技术有限公司 | 2020-10-30 | — | — | CN | claimed |
| CN-111618311-A | Silver nanoparticle dispersion liquid and preparation method and application thereof | 中国科学院化学研究所 | 2020-09-04 | — | — | CN | claimed |
| CN-111003842-A | Environment-friendly treatment method of papermaking deinking wastewater | 李洪 | 2020-04-14 | — | — | CN | claimed |
| US-9862982-B2 | Methods of hydrolyzing a cellulose using halophilic, thermostable and ionic liquids tolerant cellulases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-01-09 | — | — | US | claimed |
| US-20170029856-A1 | Useful halophilic, thermostable and ionic liquids tolerant cellulases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-02-02 | — | — | US | claimed |
| US-20140007497-A1 | BIOREFINING COMPOUNDS AND ORGANOCATALYTIC UPGRADING METHODS | UNITED STATES DEPARTMENT OF ENERGY | 2014-01-09 | — | — | US | claimed |
| US-8420732-B2 | Polybenzimidazole solution in an ionic liquid | PBI PERFORMANCE PRODUCTS, INC. (US) | 2013-04-16 | — | — | US | claimed |
| US-20130023015-A1 | Useful halophilic, thermostable and ionic liquids tolerant cellulases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-01-24 | — | — | US | claimed |
| WO-2012087442-A1 | POLYBENZIMIDAZOLE SOLUTION IN AN IONIC LIQUID | PBI PERFORMANCE PRODUCTS, INC. (US) | 2012-06-28 | — | — | WO | claimed |
| US-20120142830-A1 | POLYBENZIMIDAZOLE SOLUTION IN AN IONIC LIQUID | DAWKINS BOBBY G (US) | 2012-06-07 | — | — | US | claimed |
| US-20110152413-A1 | POLYBENZIMIDAZOLE SOLUTION IN AN IONIC LIQUID | PBI PERFORMANCE PRODUCTS, INC. | 2011-06-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140007497-A1 | BIOREFINING COMPOUNDS AND ORGANOCATALYTIC UPGRADING METHODS | HPD, HMOX2, DUOX2 | FDPS 42/4885SMN1; SMN2 3381/4885LMNA 1448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.